Find a Doctor

Newsworthy:  Top Cancer Surgeon Joins Scottsdale Healthcare

http://www.evliving.com/2009/04/09/cancer-surgeon-scottsdale-healthcare/

Dr. Ramanathan specializes in new drug development and phase 1 clinical trials for patients with advanced carcinoid and neuroendocrine tumors.

Dr. Bergsland specializes in clinical trials.

Publications http://www.corigroup.org/Bilchik%20CV%2012-4-09.pdf

Curriculum Vitae http://www.corigroup.org/Bilchik%20CV%2012-4-09.pdf

Dr. Hecht is an internationally known clinical and translational researcher in the field of gastrointestinal cancers. He has published widely on the molecular biology, early detection, and treatment of gastrointestinal malignancies. He has both clinical and research interests in the treatment of neuroendocrine tumors of the GI tract and works closely with UCLA surgeons, interventional radiologists, gastroenterologists, and endocrinologists as part of a multi-disciplinary group. He was the UCLA Principal Investigator (PI) for 4 NET trials (All 3 RADIANT trials and one IMC-A12) and has been the UCLA PI for more than 30 trials and overall PI for 14 multicenter (both US only and international) phase II and phase III trials.

Works with Dr. Richard Warner, NYC

Recruiting contact:  Allen.Cohen@USOncology.com

Resume

Comments:  "He is outstanding and works with the guys in LA all the time." KH, Colorado

Resume

Comments:  "In September 2006, Dr. Nick DiBella gave me my 25 year survival pin for having carcinoid with liver metastases for 25 years.  Perhaps I can give hope to other carcinoid patients by telling my story."  Marilyn Thurston, Pueblo, CO

Resume

Comments: "After reading (on the carcinoid ACOR list) some of the horror stories about clueless medical staff I've gained an even greater appreciation of Dr. Medgyesy's professional skills.  She isn't a carcinoid specialist per se, but knew of the disease." Woody Hesselbarth

Comments: Works with Dr. Richard Warner, NYC

Comments: Dr. Faig is caring for patients originally seen by Dr. Richard Waner, NYC, for consults and continues to communicate with Dr. Warner regarding specific problems.

Comments:  "Dr. Dubovsky is currently the President of Atlanta Cancer Care and holds positions at St. Joseph's Hospital as Chairman of the Institutional Review Board and Director of the Cancer Data Center. I have been under Dr. Dubovsky's care since March 2004.  He is very knowledgeable about carcinoid tumors and seems willing to work with specialists, namely Dr. Larry Kvols in Tampa, FL." Patricia Howard

Atlanta Cancer Care

For interventional radiology only.  Dr. Farrell's practice with oncology patients includes performing bland embolization and yttrium radioembolization on NET cancer patients.

Gastrointestinal Cancer Program

Comments:  Works with Dr. Richard Warner, NYC

Click here for more information.

Research Statement: The Genetics and Endocrinology Section studies the genetic bases of primary hyperparathyroidism and its relations to other neoplastic disorders. We have cloned the gene for multiple endocrine neoplasia type 1 and found that it is implicated in many non-hereditary tumors. This tumor suppressor gene encodes a novel protein, menin. We are studying the actions of menin protein by yeast two-hybrid, micro-array, knockout, and other approaches. We have identified an important interaction of menin with junD, a nuclear transcription factor.

Dr. Pacak is an international expert on pheochromocytoma/paraganglioma and has put together this research protocol at the NIH. He is currently working as the Chief of Section on Medical Neuroendocrinology, NICHD.

Dr. Saif is an internationally known clinical and translational researcher in the field of gastrointestinal cancers. He has published widely on the molecular biology, early detection, and treatment of gastrointestinal malignancies. He has both clinical and research interests in the treatment of GI cancers (liver, pancreas, biliary, colon, rectum, carcinoid, GIST, stomach, esophagus, anal) and works closely with Tufts surgeons, interventional radiologists, gastroenterologists, and endocrinologists as part of a multi-disciplinary group. In addition, he specializes in new drug development and phase 1 clinical trials for patients with advanced carcinoid and other GI tumors.

Dr. Rubin's research interest is in gastrointestinal tumors with a particular interest in neuroendocrine cancers (carcinoid and islet cell tumors). He has worked with Intervention Radiology in evolving techniques for clinical care. In addition, there is collaborative work with the Oncology Laboratory to look for new treatments based on molecular/genetic properties of these tumors. His laboratory has worked nationally with pharmaceutical companies in development of new treatments for these patients. In addition to GI tumors, Dr. Rubin has been involved with most of the gene therapy trials at Mayo and continues to have an interest in developing new programs of treatment. He has been involved in Mayo's phase I drug development program for many years.

Dr. Libutti’s clinical practice is focused on the surgical management of patients with cancer and endocrine neoplasms. Dr. Libutti’s research, which began at the National Cancer Institute (NCI), focuses on the formation of new blood vessels, which nourish tumors, as well as the interaction between tumor cells, endothelial cells, and components of the tumor microenvironment that influence tumor growth, invasion and spread.

D. Mechanick's clinical interests include thyroid disorders, osteoporosis, nutrition, parathyroid disease, neuroendocrinology, and endocrinology.  He currently serves on the Board of Directors of the American Association of Clinical Endocrinologists (AACE), where he is President-Elect, and is a member of the President's Council on Fitness, Sports, and Nutrition - Science Board.

Dr. Zacks has extensive experience caring for patients with carcinoid heart disease.  He is the founder of the Carcinoid Heart Center, located in New York City.

Dr. Bloomston's clinical interests focus on the management of cancers of the liver, biliary tree, and pancreas as well as neuroendocrine cancers.  Research in these areas include clinical trials, outcomes analysis, and molecular correlative studies. Basic science research deals with the role of microRNAs in pancreatic cancer.

Toledo Clinic

The Penn Neuroendocrine Tumor Treatment Program in Philadelphia is an interdisciplinary program centered on the diagnosis, staging and treatment of gastroenteropancreatic neuroendocrine tumors (GEP-NETs) and paragangliomas/pheochromocytomas (PHEOs). By treating both GEP-NETS and PHEOs, Penn has established itself as one of the only sites in the country with a unified program for both neuroendocrine tumor subtypes.  Click here to learn more about the program and the physicians who treat NET cancer patients.

Dr Chen and his research laboratory staff investigate the development, progression, and treatment of endocrine tumors including gastrointestinal carcinoids, thyroid cancer, adrenal cancer, and pancreatic islet cell tumors.

They focusing on the role of cellular signaling pathways in the differentiation and growth of neuroendocrine (NE) tumors including carcinoid, pancreatic islet cell, pheochromocytoma, and medullary thyroid cancer.

http://www.needsamedaypaydayloans.co.uk

In addition to Same Day Payday Loans this specific, you possibly can use the amount of money to meet up with ones various other monetary costs. If you'd like money with no inconvenience, and then on-line app establishes for being remarkably very theraputic for people. As compared to standard method, this kind of will be rapidly, dependable along with top secret intended for bank loan hunters. Ahead of using, be sure to accomplish many watchful analysis involving on-line monetary market. It is advisable to assess a variety of 6 thirty days bank loan bargains along with get one which could match properly having the size of ones bank account which enables it to meet your requirements without the need of difficulties. Currently load the form Same Day Payday Loans and have money straightly as part of your account in the period involving 24 hours.

Word financial Text Loans products are generally on the list of ideal approaches to purchase all-important volume with your hands and wrists within a rapidly speed. Should you be some sort of phone manager along with have to have an instantaneous fiscal back up, ones phone can help you very easily. By means of assistance from text financial products you possibly can purchase money with number of hours. To have money, most you have to do would be to type some sort of TXT plus the volume necessary by simply 12 Month Loans you may be directed at people inside very same day time of the app.

To have the benefits 6 Month Payday Loans of text financial products, you have to pick out a great monetary commence. After this, you need to sign-up ones phone variety using your bank loan loan provider. Furthermore, people must also complete ones particulars within an on-line application. In this particular type, you have to speak about ones identify, housing handle, month-to-month profits, identity resistant, therefore onwards. Once you have performed this specific, your own personal facts will be examined because of the loan provider, eventually, a e-mail IDENTITY will be directed at people, along with some sort of top secret pin number rule. You will merely send out TXT along with anticipate preferred value as part of your account inside up coming organization hours. http://www.apply4shorttermloans.co.uk

By way of text financial products, you may get your hands on money between fat 100 to be able to fat 1000. To be in the amount of bank loan, you're given repayment occasion of just one few days. Right after seven days, just how much will Short Term Loans be taken off through your account by simply electronic digital suggests. The interest pace charged by simply financial company will be little bit higher caused by quick maturation.

Currently stop weeping more than ones pecuniary things along with incur wished money in ones bank account within a speedy technique by using text financial products.http://www.easytextpaydayloans.co.uk

http://stage.ilportaledellimbianchino.it/imprese/same-day-loanshttpwwwneedsamedaypaydayloanscouk

http://www.blogfortrader.com/forum/3-month-loans-3monthloanszcouk#comment-17373

http://www.mysl.org/same-day-loanshttpwwwneedsamedaypaydayloanscouk

http://www.newleafcs.com/same-day-loanshttpwwwneedsamedaypaydayloanscouk

Dr. Pinto's specialties include medical oncology; health care administration; cancer programs and projects: planning and development.

AmMed International is building a network of comprehensive ambulatory cancer diagnosis and treatment centers in Asia. It provides comprehensive cancer screening services including PET-CT imaging, medical oncology services, chemotherapy infusion, and radiotherapy using an IMRT linear accelerator. A complete center at the Adventist Hospital in Hong Kong has been in operation since 2002 and is now supported by a satellite clinic in Central. A new center in Kowloon is being set up. AmMed is affiliated with the Memorial Sloan-Kettering Cancer Institute in New York.

Office hours, by appointment, are Monday through Friday, 8:30 am to 5:30 pm, closed on Saturdays and public holidays.

The postal address is:
P.O. Box 2040
3000 CA Rotterdam, Netherlands

Erasmus MC Lutetium 177 Treatment*
Information about the Receptor therapy given to patients in the Netherlands ......Read More

Prof. Dr. Eric Krenning is the Head of the Department of Nuclear Medicine at Erasmus.

Dr. Liau has a research interest in surgical treatment of hepatobiliary cancers, in particular, hepatocellular carcinoma (liver cancer), cholangiocarcinoma (bile duct cancer), gallbladder carcinoma (gallbladder cancer), pancreatic adenocarcinoma (pancreas cancer), pancreatic neuroendocrine tumors (i.e. insulinoma, glucogonoma, VIPoma, gastrinoma, etc.), gastrointestinal neuroendocrine neoplasm and metastatic neuroendocrine tumors to the liver.  He has also dedicated signficant effort to understand molecular basis, nuclear and novel mangement of liver, pancreatic cancers, and neuroendocrine tumors.

The section of Endocrine Oncology, Uppsala University Hospital, is the national referal center for patients with neuroendocrine tumors. At the section of Endocrine Oncology basic scientific research is combined with improvement of diagnostic procedures and medical treatment of neuroendocrine tumors. To the specialized ward with 15 beds patients are referred from all over Sweden as well as from the Nordic countries, Europe, the Middle East, South America and USA for diagnosis and treatment.

Members of the Endocrine Oncology Department are:

• Professor: Kjell Öberg, Chairman Department of Medical Sciences, Vice Chairman Division of Internal Medicine

• Associate Professor: Barbro Eriksson, Head Section of Endocrine Oncology, Member of ENET

• Associate Professor: Britt Skogseid, Consultant in Endocrinology and Medicine

• Associate Professor: Eva Tiensuu Janson, Dr Med Sc Anders Gobl, Molecular Biologist

• Head Nurse: Monica Hurtig

• Research Nurse: Gunnel Larsson

• Consultant Doctor: Dan Granberg

Professor Bloom's research work over the years falls into five related categories: endocrinology clinical research, physiology and pathology of gut hormones, control of insulin release and insulin resistance, role of neuropeptides in organ control and the role of neuropeptides in CNS regulation of appetite and related hypothalamic functions. He currently leads a research group investigating hypothalamic appetite control systems and gut hormones.